721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection
Open Access
- 9 November 2020
- journal article
- abstracts
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 8 (Suppl 3), A763
- https://doi.org/10.1136/jitc-2020-sitc2020.0721